K.M., C.E. Goldkamp, H.N. Erb, et al. 2006. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993–2003). J Am Vet Med Assoc 229:401–406.566 Rassnick, K.M., G.E. Mauldin, R. Al‐Sarraf, et al. 2002. Mopp chemotherapy for treatment of resistant lymphoma in dogs: A retrospective study of 117 cases (1989–2000). J Vet Intern Med 16:576–580.
567 Rassnick, K.M., M.C. McEntee, H.N. Erb, et al. 2007. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma. J Vet Intern Med 21:1364–1373.
568 Rassnick, K.M., A.S. Moore, D.S. Russell, et al. 2010. Phase II, open‐label trial of single‐agent CCNU in dogs with previously untreated histiocytic sarcoma. J Vet Intern Med 24:1528–1531.
569 Rassnick, K.M., A.S. Moore, L.E. Williams, et al. 1999. Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 13:601–605.
570 Rassnick, K.M., D.M. Ruslander, S.M. Cotter, et al. 2001. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989–2000). J Am Vet Med Assoc 218:1444–1448.
571 Rebhun, R.B., M.S. Kent, S.A. Borrofka, et al. 2011. Chop chemotherapy for the treatment of canine multicentric T‐cell lymphoma. Vet Comp Oncol 9:38–44.
572 Renwick, A. and E. Scurrell. 2013. Orthogonal bone plate stabilization for limb‐sparing surgery. Vet Comp Orthop Traumatol 26:505–509.
573 Huppes, R.R., L.Z. Crivellenti, A. Barboza De Nardi, et al. 2017. Radical cystectomy and cutaneous ureterostomy in 4 dogs with trigonal transitional cell carcinoma: Description of technique and case series. Vet Surg 46:111–119.
574 Riccardo, F., S. Iussich, L. Maniscalco, et al. 2014. CSPG4‐specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA. Clin Cancer Res 20:3753–3762.
575 Ridgway, T.D. and M.D. Lucroy. 2003. Phototoxic effects of 635‐nm light on canine transitional cell carcinoma cells incubated with 5‐aminolevulinic acid. Am J Vet Res 64:131–136.
576 Robat, C., J. Burton, D. Thamm, et al. 2013a. Retrospective evaluation of doxorubicin‐piroxicam combination for the treatment of transitional cell carcinoma in dogs. J Small Anim Pract 54:67–74.
577 Robat, C.S., L. Cesario, R. Gaeta, et al. 2013b. Clinical features, treatment options, and outcome in dogs with thymoma: 116 cases (1999–2010). J Am Vet Med Assoc 243:1448–1454.
578 Robat, C., C. London, L. Bunting, et al. 2012. Safety evaluation of combination vinblastine and toceranib phosphate (Palladia(R)) in dogs: A phase I dose‐finding study. Vet Comp Oncol 10:174–183.
579 Robben, J.H., W.E. Van Den Brom, J.A. Mol, et al. 2006. Effect of octreotide on plasma concentrations of glucose, insulin, glucagon, growth hormone, and cortisol in healthy dogs and dogs with insulinoma. Res Vet Sci 80:25–32.
580 Rodenas, S., I. Valin, P. Devauchelle, et al. 2006. Combined use of surgery and radiation in the treatment of an intradural myxoid liposarcoma in a dog. J Am Anim Hosp Assoc 42:386–391.
581 Romansik, E.M., C.M. Reilly, P.H. Kass, et al. 2007. Mitotic index is predictive for survival for canine cutaneous mast cell tumors. Vet Pathol 44:335–341.
582 Rosales, C., K.A. Jeglum, M. Obrocka, et al. 1988. Cytolytic activity of murine anti‐dog lymphoma monoclonal antibodies with canine effector cells and complement. Cell Immunol 115:420–428.
583 Ross, J.T., T.D. Scavelli, D.T. Matthieson, et al. 1991. Adenocarcinoma of the apocrine glands of the anal sac in dogs: A review of 32 cases. J Am Anim Hosp Assoc 27:349–355.
584 Rottenberg, S., C. Von Tscharner, and P.J. Roosje. 2004. Thymoma‐associated exfoliative dermatitis in cats. Vet Pathol 41:429–433.
585 Rovesti, G.L., M. Bascucci, K. Schmidt, et al. 2002. Limb sparing using a double bone‐transport technique for treatment of a distal tibial osteosarcoma in a dog. Vet Surg 31:70–77.
586 Rusbridge, C., S.J. Wheeler, C.R. Lamb, et al. 1999. Vertebral plasma cell tumors in 8 dogs. J Vet Intern Med 13:126–133.
587 Saam, D.E., J.M. Liptak, M.J. Stalker, et al. 2011. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996–2006). J Am Vet Med Assoc 238:195–206.
588 Saba, C.F., S.D. Hafeman, D.M. Vail, et al. 2009. Combination chemotherapy with continuous L‐asparaginase, lomustine, and prednisone for relapsed canine lymphoma. J Vet Intern Med 23:1058–1063.
589 Saba, C.F., D.H. Thamm, and D.M. Vail. 2007. Combination chemotherapy with L‐asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma. J Vet Intern Med 21:127–132.
590 Saba, C.F., D.M. Vail, and D.H. Thamm. 2012. Phase II clinical evaluation of lomustine chemotherapy for feline vaccine‐associated sarcoma. Vet Comp Oncol 10:283–291.
591 Saeki, K., A. Fujita, N. Fujita, et al. 2015. Total cystectomy and subsequent urinary diversion to the prepuce or vagina in dogs with transitional cell carcinoma of the trigone area: A report of 10 cases (2005–2011). Can Vet J 56:73–80.
592 Salinardi, B.J., S.L. Marks, J.R. Davidson, et al. 2003. The use of a low‐profile cystostomy tube to relieve urethral obstruction in a dog. J Am Anim Hosp Assoc 39:403–405.
593 Salm, R., B. Wullich, G. Kiefer, et al. 1991. Effects of a three‐drug antineoplastic protocol of wound healing in rats: A biomechanical and histologic study on gastrointestinal anastomoses and laparotomy wounds. J Surg Oncol 47:5–11.
594 Santos, A.A., C.C. Lopes, J.R. Ribeiro, et al. 2013. Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study. BMC Vet Res 9:1.
595 Sartor, L.L., L.A. Trepanier, M.M. Kroll, et al. 2004. Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism. J Vet Intern Med 18:651–655.
596 Sauerbrey, M.L., M.N. Mullins, E.O. Bannink, et al. 2007. Lomustine and prednisone as a first‐line treatment for dogs with multicentric lymphoma: 17 cases (2004–2005). J Am Vet Med Assoc 230:1866–1869.
597 Saulnier‐Troff, F.G., V. Busoni, and A. Hamaide. 2008. A technique for resection of invasive tumors involving the trigone area of the bladder in dogs: Preliminary results in two dogs. Vet Surg 37:427–437.
598 Scase, T.J., D. Edwards, J. Miller, et al. 2006. Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis. J Vet Intern Med 20:151–158.
599 Schrempp, D.R., M.O. Childress, J.C. Stewart, et al. 2013. Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma. J Am Vet Med Assoc 242:1534–1538.
600 Schuller, D.E., B. Metch, D.W. Stein, et al. 1988. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 98:1205–1211.
601 Schultheiss, P.C. 2004. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Invest 16:522–526.
602 Schwarz, P.D., S.J. Withrow, C.R. Curtis, et al. 1991b. Mandibular resection as a treatment for oral cancer in 81 dogs. J Am Anim Hosp Assoc 27:601–610.
603 Schwarz, P.D., S.J. Withrow, C.R.
